Reproductive and hormonal factors in relation to incidence of sarcoidosis in US black women

American Journal of Epidemiology

Volumn 176, Issue 7, 2012, Pages 635-641

  Cozier, Yvette C ^a   Berman, Jeffrey S ^b   Palmer, Julie R ^a   Boggs, Deborah A ^a   Wise, Lauren A ^a   Rosenberg, Lynn ^a  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African Americans; hormones; prospective studies; reproduction; risk factors; sarcoidosis; women; women's health

Indexed keywords

ESTROGEN; HORMONE; ORAL CONTRACEPTIVE AGENT;

AFRICAN AMERICAN; BLACK POPULATION; DISEASE INCIDENCE; HORMONE; PREGNANCY; RISK FACTOR; WOMENS HEALTH;

ADULT; AGED; ARTICLE; BIRTH; BODY MASS; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; NEGRO; PREGNANCY; QUESTIONNAIRE; REPRODUCTION; SARCOIDOSIS; SMOKING;

ADULT; AFRICAN AMERICANS; AGED; CONTRACEPTIVES, ORAL, HORMONAL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; HEALTH SURVEYS; HUMANS; INCIDENCE; MATERNAL AGE; MENARCHE; MENOPAUSE; MIDDLE AGED; PARITY; PARTURITION; PREGNANCY; PROPORTIONAL HAZARDS MODELS; QUESTIONNAIRES; REPRODUCTIVE HISTORY; SARCOIDOSIS; UNITED STATES;

UNITED STATES;

EID: 84866913803     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kws145     Document Type: Article

References (54)

1. Bresnitz EA, Strom BL. Epidemiology of sarcoidosis. Epidemiol Rev. 1983;5:124-156. (Pubitemid 14238316)
2. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997;336(17):1224-1234.
3. Rybicki BA, Major M, Popovich J Jr, et al. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol. 1997;145(3):234-241.
4. Rybicki BA, Maliarik MJ, Major M, et al. Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect. 1998;13(3):166-173. (Pubitemid 28440835)
5. Sutherland I, Mitchell DN, Hart PD. Incidence of intrathoracic sarcoidosis among young adults participating in a trial of tuberculosis vaccines. Br Med J. 1965; 2(5460):497-503.
6. Terris M, Chaves AD. An epidemiologic study of sarcoidosis. Am Rev Respir Dis. 1966;94(1):50-55.
7. Henke CE, Henke G, Elveback LR, et al. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival. Am J Epidemiol. 1986; 123(5):840-845. (Pubitemid 16049241)
8. Hillerdal G, Nöu E, Osterman K, et al. Sarcoidosis: epidemiology and prognosis. A 15-year European study. Am Rev Respir Dis. 1984;130(1):29-32. (Pubitemid 14092975)
9. Byg KE, Milman N, Hansen S. Sarcoidosis in Denmark 1980-1994. A registry-based incidence study comprising 5536 patients. Sarcoidosis Vasc Diffuse Lung Dis. 2003; 20(1):46-52. (Pubitemid 36559733)
10. Kitamura K, Shigematsu I, Hosoda Y. Sarcoidosis in Japan. Observations on 700 cases. Am Rev Respir Dis. 1967; 96(5):952-956.
11. Shirai M, Sato A, Chida K. The influence of ovarian hormones on the granulomatous inflammatory process in the rat lung. Eur Respir J. 1995;8(2):272-277.
12. Lofgren S, Lundback H. The bilateral hilar lymphoma syndrome; a study of the relation to age and sex in 212 cases. Acta Med Scand. 1952;142(4):259-264.
13. Mayock RL, Sullivan RD, Greening RR, et al. Sarcoidosis and pregnancy. J Am Med Assoc. 1957;164(2):158-163.
14. O'Leary JA. Ten-year study of sarcoidosis and pregnancy. Am J Obstet Gynecol. 1962;84:462-466.
15. Cipriani A, Casara D, Di Vittorio G, et al. Sarcoidosis and pregnancy. Sarcoidosis. 1991;8(2):183-185.
16. Selroos O. Sarcoidosis and pregnancy: a review with results of a retrospective survey. J Intern Med. 1990;227(4): 221-224. (Pubitemid 20105751)
17. Agha FP, Vade A, Amendola MA, et al. Effects of pregnancy on sarcoidosis. Surg Gynecol Obstet. 1982;155(6):817-822. (Pubitemid 13198475)
18. Haynes de Regt R. Sarcoidosis and pregnancy. Obstet Gynecol. 1987;70(3 pt 1):369-372.
19. Iwai K, Sekiguti M, Hosoda Y, et al. Racial difference in cardiac sarcoidosis incidence observed at autopsy. Sarcoidosis. 1994;11(1):26-31.
20. Milman N, Selroos O. Pulmonary sarcoidosis in the Nordic countries 1950-1982. II. Course and prognosis. Sarcoidosis. 1990;7(2):113-118.
21. Eggelmeijer F, Dijkmans BA. Sarcoidosis post partum: a description of four cases. Br J Rheumatol. 1989;28(3):270-271.
22. Martin WJ II, Iannuzzi MC, Gail DB, et al. Future directions in sarcoidosis research: summary of an NHLBI working group. Am J Respir Crit Care Med. 2004;170(5):567-571. (Pubitemid 39209141)
23. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153-2165.
24. James DG, Hosoda Y. Epidemiology. In: James DG, ed. Sarcoidosis and Other Granulomatous Disorders. New York, NY: Marcel Dekker; 1994:729-743.
25. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis. 1987; 135(3):747-760. (Pubitemid 17041617)
26. Agostini C, Trentin L, Facco M, et al. Role of IL-15, IL-2, and their receptors in the development of T cell alveolitis in pulmonary sarcoidosis. J Immunol. 1996;157(2):910-918. (Pubitemid 26231399)
27. Baughman RP, Strohofer SA, Buchsbaum J, et al. Release of tumor necrosis factor by alveolar macrophages of patients with sarcoidosis. J Lab Clin Med. 1990;115(1):36-42. (Pubitemid 20044133)
28. Moller DR, Forman JD, Liu MC, et al. Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol. 1996;156(12):4952-4960. (Pubitemid 26174485)
29. Iannuzzi MC, Fontana Jr. Sarcoidosis: clinical presentation, immunopathogenesis and therapeutics. JAMA. 2011;305(4): 391-399.
30. Valentonyte R, Hampe J, Huse K, et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet. 2005;37(4):357-364.
31. Rybicki BA, Walewski JL, Maliarik MJ, et al. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. ACCESS Research Group. Am J Hum Genet. 2005;77(3):491-499. (Pubitemid 41192655)
32. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol. 2001;2(9):777-780.
33. McCarthy M. The "gender gap" in autoimmune disease. Lancet. 2000;356(9235):1088.
34. Palmer JR, Wise LA, Horton NJ, et al. Dual effect of parity on breast cancer risk in African-American women. J Natl Cancer Inst. 2003;95(6):478-483. (Pubitemid 36432422)
35. Cozier YC, Berman JS, Palmer JR, et al. Sarcoidosis in black women in the United States: data from the Black Women's Health Study. Chest. 2011;139(1):144-150.
36. SAS Institute Inc. SAS/STAT User's Guide, Version 9.1. Cary, NC: SAS Institute Inc; 2004.
37. Therneau TM. Extending the Cox Model. New York, NY: Springer-Verlag New York; 1997.
38. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Case Control Etiologic Study of Sarcoidosis (ACCESS) Research Group. Am J Respir Crit Care Med. 2001;164(10):1885-1889. (Pubitemid 33152325)
39. ACCESS Research Group. Design of A Case Control Etiologic Study of Sarcoidosis (ACCESS). J Clin Epidemiol. 1999;52(12):1173-1186.
40. Newman LS, Rose CS, Bresnitz EA, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. ACCESS Research Group. Am J Respir Crit Care Med. 2004;170(12):1324-1330. (Pubitemid 39657197)
41. Iannuzzi MC, Iyengar SK, Gray-McGuire C, et al. Genomewide search for sarcoidosis susceptibility genes in African Americans. Genes Immun. 2005;6(6):509-518. (Pubitemid 43090509)
42. Berman RH. Sarcoidosis benefited by pregnancy; report of a case. J Am Med Assoc. 1951;147(3):246-248.
43. Donaldson SW, Tompsett AC, Grekin RH, et al. Sarcoidosis. V. The effects of pregnancy on the course of the disease. Ann Intern Med. 1951;34(5):1213-1218.
44. Dines DE, Banner EA. Sarcoidosis during pregnancy. Improvement in pulmonary function. JAMA. 1967; 200(8):726-727.
45. Brien TG, Dalrymple IJ. Longitudinal study of the free cortisol index in pregnancy. Br J Obstet Gynaecol. 1976; 83(5):361-367.
46. Chida K, Shirai M, Sato M, et al. Successful treatment of hepatic sarcoidosis with hormone replacement in a postmenopausal woman. Respirology. 1999;4(3):259-261. (Pubitemid 29434471)
47. Rosenberg L, Palmer JR, Wise LA, et al. A prospective study of female hormone use and breast cancer among black women. Arch Intern Med. 2006;166(7):760-765.
48. Palmer JR, Boggs DA, Wise LA, et al. Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev. 2011;20(9):1883-1891.
49. Wise LA, Palmer JR, Harlow BL, et al. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol. 2004;159(2):113-123. (Pubitemid 38082518)
50. El Jundi O, Karakaya G, Fuat Kalyoncu A. Sarcoidosis following specific immunotherapy: more than just coincidence? Allergol Immunopathol (Madr). 2007; 35(1):32-34. (Pubitemid 46536252)
51. Morgenthau AS, Iannuzzi MC. Recent advances in sarcoidosis. Chest. 2011;139(1):174-182.
52. Chen ES, Wahlström J, Song Z, et al. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J Immunol. 2008; 181(12):8784-8796.
53. Song Z, Marzilli L, Greenlee BM, et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med. 2005;201(5):755-767. (Pubitemid 40395121)
54. Day JC, Curry AE. Educational Attainment in the United States: March 1998 (Update). Washington, DC: Bureau of the Census, US Department of Commerce; 1998: P20-P543.